Pharmanovia enters in-licensing agreement with Axsome Therapeutics to market and further develop...
More informationPharmanovia, The Life Cycle Management Company, today confirmed that it has made two key appointments in China...
More informationDr Claire Ives (Senior MSL Director) and Dr Fernando Osorio (MSL Director) will together head Pharmanovia’s influential Medical...
More informationFor Trade and Medical Media ONLY PHARMANOVIA EXCLUSIVELY LICENCES RIGHTS FOR A NOVEL WAY OF TREATING...
More informationDKSH will support life cycle management company Pharmanovia in its mission to bring important medication to...
More informationLondon (UK), 20 June 2022 Ian King interviews Pharmavovia’s CEO, Dr James Burt on SkyNews
More informationPharmanovia has acquired the commercial rights in China for Rocaltrol® (calcitriol) Roche. Pharmanovia obtained the...
More informationThe report celebrates the firm’s diversity and sets out ambitious environmental and sustainability targets London, UK...
More informationLONDON – Alastair Hay is leaving his position as Chief Corporate Development Officer at the global...
More informationFor all media enquiries please contact: communications@pharmanovia.com